Sun Pharma Falls Short of Debt Fundraise Goal as Investors Seek Higher Yields
Three merchant bankers said Sun Pharmaceutical Industries fell short of its targeted debt fundraise as investors continued to demand higher yields.
India's Sun Pharmaceutical Industries (NSE:SUNPHARMA) did not meet its targeted debt fundraising amount, as investors continued to seek higher yields, three merchant bankers said on Thursday. ($1 = 94.8950 Indian rupees)